publication venue for
- Tissue-specific induced DNA methyltransferase 1 (Dnmt1) in endocrine pancreas by RCAS-TVA-based somatic gene transfer system promotes β-cell proliferation.. 26. 2018
- Genetic modification of neurons to express bevacizumab for local anti-angiogenesis treatment of glioblastoma.. 22. 2014
- Role of MAPK in oncolytic herpes viral therapy in triple-negative breast cancer.. 21. 2014
- Intraprostatic distribution and long-term follow-up after AdV-tk immunotherapy as neoadjuvant to surgery in patients with prostate cancer.. 20. 2013
- Additive antileukemia effects by GFI1B- and BCR-ABL-specific siRNA in advanced phase chronic myeloid leukemic cells.. 20. 2013
- A triple suicide gene strategy that improves therapeutic effects and incorporates multimodality molecular imaging for monitoring gene functions.. 20. 2013
- Molecular network pathways and functional analysis of tumor signatures associated with development of resistance to viral gene therapy.. 19. 2011
- Retargeting NK92 cells using an HLA-A2-restricted, EBNA3C-specific chimeric antigen receptor.. 19. 2011
- Persistent expression of biologically active anti-HER2 antibody by AAVrh.10-mediated gene transfer.. 17. 2010
- Synergistic growth inhibition of anaplastic large cell lymphoma cells by combining cellular ALK gene silencing and a low dose of the kinase inhibitor U0126.. 17. 2010
- Combination of human tumor necrosis factor-alpha (hTNF-alpha) gene delivery with gemcitabine is effective in models of pancreatic cancer.. 16. 2009
- Calcium depletion enhances nectin-1 expression and herpes oncolytic therapy of squamous cell carcinoma.. 14. 2007
- Cytokine-secreting herpes viral mutants effectively treat tumor in a murine metastatic colorectal liver model by oncolytic and T-cell-dependent mechanisms.. 14. 2007
- Lentiviral vector neutral endopeptidase gene transfer suppresses prostate cancer tumor growth.. 14. 2007
- Delivery of replication-competent retrovirus expressing Escherichia coli purine nucleoside phosphorylase increases the metabolism of the prodrug, fludarabine phosphate and suppresses the growth of bladder tumor xenografts.. 14. 2007
- Treatment of cholangiocarcinoma with oncolytic herpes simplex virus combined with external beam radiation therapy.. 13. 2006
- Minimally invasive localization of oncolytic herpes simplex viral therapy of metastatic pleural cancer.. 13. 2006
- Positron emission tomography (PET) imaging of tumor-localized Salmonella expressing HSV1-TK.. 12. 2005
- Chemosensitizing tumor cells by targeting the Fanconi anemia pathway with an adenovirus overexpressing dominant-negative FANCA.. 11. 2004
- Acquired resistance to cytolysis of the E1B-attenuated adenovirus, dl1520, in ovarian tumour cell lines.. 10. 2003
- Neoadjuvant treatment of hepatic malignancy: an oncolytic herpes simplex virus expressing IL-12 effectively treats the parent tumor and protects against recurrence-after resection.. 10. 2003
- Development of lentiviral vectors for antiangiogenic gene delivery.. 8. 2001
- Combination gene therapy using multiple immunomodulatory genes transferred by a defective infectious single-cycle herpes virus in squamous cell cancer.. 7. 2000
- Efficient cotransduction of tumors by multiple herpes simplex vectors: implications for tumor vaccine production.. 7. 2000
- Regional treatment of hepatic micrometastasis by adenovirus vector-mediated delivery of interleukin-2 and interleukin-12 cDNAs to the hepatic parenchyma.. 6. 1999
- Experimental gene therapy against subcutaneously implanted glioma with a herpes simplex virus-defective vector expressing interferon-gamma.. 6. 1999
- Use of L-plastin promoter to develop an adenoviral system that confers transgene expression in ovarian cancer cells but not in normal mesothelial cells.. 6. 1999
- Local inflammatory response and vector spread after direct intraprostatic injection of a recombinant adenovirus containing the herpes simplex virus thymidine kinase gene and ganciclovir therapy in mice.. 5. 1998
- Can gene therapy be used to prevent cancer? Gene therapy for aldehyde dehydrogenase 2 deficiency. 2021